NOC · Q2 2025 Earnings
BullishNorthrop Grumman
Reported July 22, 2025
30-second summary
Northrop raised FY25 sales, segment income, EPS, and free cash flow guidance after a quarter where Mission Systems grew 14% and a positive Sentinel earnings adjustment landed alongside resumed work on the command-and-launch segment. Headline revenue of $10.35B (+1.3% YoY) was held back by a $283M Space wind-down headwind, but the underlying narrative is a generational shift: $4.5B of reconciliation funding for B-21 production capacity, NATO members committing toward 3.5% core defense and 5% broader national security as a share of GDP, and international sales +18% YoY. Backlog at $89.7B and book-to-bill of ~0.7x for the quarter give multi-year visibility; the open question is what NOC has to invest to unlock the B-21 ramp.
Headline numbers
EPS
Q2 FY2025
$8.15
Revenue
Q2 FY2025
$10.35B
+1.3% YoY
Free cash flow
Q2 FY2025
$0.64B
Operating margin
Q2 FY2025
13.8%
Key financials
Q2 FY2025| Metric | Q2 FY2025 | YoY |
|---|---|---|
| Revenue | $10.35B | +1.3% |
| EPS | $8.15 | — |
| Operating margin | 13.8% | — |
| Free cash flow | $0.64B | — |
Guidance
Prior quarter data unavailable — comparison not possible.
Segment KPIs
Q2 FY2025| Segment | Q2 FY2025 | YoY |
|---|---|---|
| Aeronautics Systems | $3.114B | +2.0% |
| Defense Systems | $1.991B | +7.0% |
| Mission Systems | $3.157B | +14.0% |
| Space Systems | $2.646B | -12.0% |
Other KPIs
Q2 FY2025| Segment | Q2 FY2025 |
|---|---|
| Segment Operating Margin Rate | 11.8% |
| Total Backlog | $89.7 billion |
| Funded Backlog | $37.5 billion |
| Net Awards | $7.4 billion |
| International Sales Growth | 18% |
| Share Repurchases and Dividends | $700 million |
Management tone
Management's posture this quarter is notably forward-leaning for a prime contractor — articulating specific catalysts (Golden Dome, NATO 3.5/5% of GDP, B-21 acceleration, solid rocket motor capacity doubling) rather than the usual generic macro tailwinds. Confidence reads as a 4/5.
Sentinel went from overhang to contributor. The program was a source of risk in prior commentary, with work suspended on the command-and-launch segment. This quarter management cited "strong Sentinel growth as well as a positive earnings adjustment, reflecting the agreements we reached with our customer, and improved confidence in achieving various performance incentives." The shift signals that the EAC risk has narrowed materially and Sentinel is now a 2H growth contributor rather than a watch-item.
B-21 reframed from capacity-constrained to acceleration-funded. Where production rate had previously been described as a limitation, the reconciliation bill added $4.5B for capacity, and management is now "in discussions with the Air Force regarding the potential for an accelerated production ramp" with "the opportunity to earn improved returns on the LRIP and NTE production lots." This is the most important strategic development on the call — NOC is negotiating for pricing upside on its largest program rather than defending economics.
International tailwind escalated from steady to generational. Prior framing treated international as a steady contributor; this quarter it grew 18% YoY (14% YTD) and management characterized European demand as "a generational shift in defense spending that's underway in Europe," explicitly citing NATO commitments toward 3.5% and 5% of GDP. The language deliberately rejects cyclical interpretation.
Capacity investment narrative moved from defensive to offensive. Management telegraphed plans to "increase our total annual solid rocket motor production rate from 13,000 units today to 25,000 by 2029," backed by $1B invested over the past six years. Doubling capacity in four years is a commitment to a sustained demand outlook, not a hedge against a peak.
Hedging where it should hedge. B-21 acceleration timing and structure remain "subject to further investment by the company," and management was careful that "the ultimate outcome of these discussions remain uncertain." The honest framing of negotiation risk reinforces credibility on the items they did claim conviction on.
Recurring themes management leaned on this quarter:
Risks management surfaced:
Q&A highlights
Seth Seidman · JP Morgan
Can Northrop revise outlook on B21 and Sentinel percentage of company sales given reconciliation bill funding, and what impact on $4 billion cash flow outlook for 2028?
B21 could now exceed 10% of total revenue in the future depending on production rate ramp, with more clarity in coming months. Sentinel not expected to reach 10% in next couple years but could grow significantly in production phase. Investments should improve long-term profitability and cash flow.
Richard Safran · Seaport Research Partners
What is the contracting environment like with new administration regarding terms, conditions, and incentives? Is international growth more DCS or FMS, and what mix should we expect going forward?
Administration focused on speed and breaking barriers in contracting; early-stage reviews underway but seeing positive impact. International mix of DCS and FMS expected to continue; FMS more appropriate for complex efforts with US government involvement, DCS more expeditious for munitions from production lines.
Jason Gursky · Citi
Can you elaborate on investments in new areas mentioned in opening remarks? How does Northrop handle the shift from exquisite systems to lower-cost, attributable systems, and can the company do both?
Beacon mission testbed is a key investment enabling industry partnerships to leverage Northrop's 500,000+ autonomous vehicle hours and physics-based modeling. Expects future warfare to be combination of exquisite and lower-cost systems working together. Northrop operates across full spectrum except very low-cost fully attributable units, using teaming constructs rather than selling hardware alone.
David Strauss · Barclays
What is the status of F-35 work including center fuselage, APG81 radar, and delayed next-gen radar modernization? Regarding B21 production ramp, if increased production is agreed with Air Force, would there be further charges or would improvements be part of arrangement?
Northrop performing well on F-35 production including center fuselage and APG81 radar. APG-85 radar fielding in development; more details forthcoming but cannot discuss due to classification. For B21, future production investments would be accompanied by improved return opportunities negotiated with Air Force, with no anticipated additional charges if production increase is agreed.
Miles Walton · Wolf Research
Is the $200 million R&D capitalization reversal benefit in addition to the absence of $250 million capitalization headwind previously anticipated? Regarding space-based interceptors, are these currently being tested on-orbit and are they directed energy or kinetic?
The $200 million benefit from tax reform cash benefits is separate from previous capitalization guidance management. Space-based interceptor testing is currently ground-based only due to competitive sensitivity; kinetic vs. directed energy approach not disclosed. Capability believed able to be accelerated to administration's desired timeframe.
What to watch into next quarter
B-21 acceleration deal structure. Does NOC disclose the terms of the Air Force negotiation, and specifically whether LRIP/NTE return improvements are quantified? Management said "more clarity in the coming months" — Q3 is the deadline by which markets will start discounting either way.
Space Systems inflection. Watch whether the YoY decline narrows from -12% as program wind-downs lap and Golden Dome awards begin to flow. A -high-single-digit Q3 print would mark the turn.
Sentinel EAC stability. This quarter's positive earnings adjustment needs to not reverse. Any negative Sentinel EAC commentary in Q3 would be a meaningful signal that the recent agreement framework is fragile.
Segment margin trajectory. Management guided "consistent with first half" (11.8% in Q2). Watch for any drift below 11.5% in Q3 given the heavier investment cadence implied for B-21 capacity.
Book-to-bill. Q2 net awards of $7.4B against $10.35B of sales is a ~0.7x quarter. A second sub-1x quarter would matter; international and Sentinel awards are the swing factors.
2028 FCF roadmap update. Management said the ~$4B figure will be refreshed once B-21 arrangements settle. Timing and direction of that update is a material event.
Sources
- NOC Q2 2025 earnings release (SEC filing): https://www.sec.gov/Archives/edgar/data/1133421/000113342125000047/noc-06302025xearningsrelea.htm
- NOC Q2 2025 earnings call commentary (as captured in tone and Q&A extraction)
Get the next brief, free.
We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.
This is not investment advice.